• ASX 200 jumps 2.4%, unloved shares keep rising

    ASX 200

    The S&P/ASX 200 Index (ASX: XJO) has continued to recover strongly.

    Over the weekend New Zealand officially declared itself COVID-19 free. Most Australian states reported no new cases. International share markets performed well on Monday, so it was not surprising to see the ASX do well too.

    Unloved shares keep bouncing

    Some of the ASX 200 shares to have seen the biggest selloff during the coronavirus crash are among the ones bouncing back the hardest today.

    The Credit Corp Group Limited (ASX: CCP) share price jumped 15.7% today.

    The Worley Ltd (ASX: WOR) share price increased by 14.6%.

    Virgin Money UK Plc (ASX: VUK) saw its share price rise by 14.3%.

    The Flight Centre Travel Group Ltd (ASX: FLT) share price soared 13.8% higher.

    The Scentre Group (ASX: SCG) share price went up almost 10%.

    Wesfarmers Ltd (ASX: WES) retail trading update

    The (mostly) retail ASX 200 conglomerate released an impressive trading update today.

    In the second half of FY20 to 31 May 2020, Wesfarmers has seen strong growth. Bunnings sales were up 19.2% compared to the prior corresponding period. Officeworks sales were up 27.8%. Catch’s gross transaction value was up 68.7%. Kmart sales were up 4.1%. Only Target has seen a revenue decline in the second half, with sales retreating 1.8%.

    Excluding Catch, Wesfarmers’ online sales are up 60% in the financial year to date.

    However, whilst sales are up strongly, costs have risen too for the ASX 200 company because of coronavirus restrictions and expenses to ensure safe stores.

    CSL Limited (ASX: CSL) share price drops on acquisition

    The ASX 200 biotech giant’s share price fell over 2% today after announcing an acquisition. The falling US dollar isn’t helping either.

    CSL is exercising its option to acquire biotech company Vitaeris. This company is a clinical-stage biotechnology company focused on the phase III development of a treatment for rejection in solid organ kidney transplant patients.

    CSL said the cost of the acquisition is modest and does not materially change the company’s profit expectation for 2020. However, there will be extra R&D expenses in FY21 estimated to be between $30 million to $50 million.

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading over 30% off it’s all-time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    As of 2/6/2020

    More reading

    Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool Australia has recommended Flight Centre Travel Group Limited and Scentre Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX 200 jumps 2.4%, unloved shares keep rising appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30mWc2F

  • Novonix share price skyrockets 77% after announcing patented manufacturing method

    Rocket soaring through the sky

    The Novonix Ltd (ASX: NVX) share price was one of the standout performers on the ASX today, finishing the day 76.64% higher at $1.21. This rise takes the company’s current market capitalisation to just under $260 million.

    Novonix is an integrated developer and supplier of materials, equipment and services for the global lithium-ion battery industry.

    The company has operations in the US and Canada, and sales in more than 14 countries across the globe. Its customer base comprises leading global brands like Samsung, Apple, Honda, Panasonic, and Sanyo.

    What caused the Novonix share price to surge?

    This morning, Novonix revealed it has developed an advanced cathode material manufacturing method using its proprietary dry particle microgranulation (DPMG) technique. The manufacturing method relates to new single crystal cathode materials and processes.

    The breakthrough of the DPMG technique was reported to the market on 15 May 2020. The company believes that today’s announcement further demonstrates the commercial application of DPMG.

    Single crystal cathode materials have reportedly demonstrated outperformance over the current standard, possessing enhanced energy density and ultra-long life when used in electric vehicles (EVs) and energy storage systems.

    The significance of single crystal cathode was highlighted in The Journal of The Electrochemical Society. A 2019 paper published by Professor Jeff Dahn and his team concluded that cells of this type should be able to power an EV for over 1.6 million kilometres and last at least 2 decades in grid energy storage.

    The new single crystal cathode materials and DPMG method were developed by the Professor Mark Obrovac Research Group at Dalhousie University. This group has been funded by Novonix in partnership with the Canadian government.

    Under the commercialisation arrangements with Professor Obrovac and Dalhousie University, Novonix owns the intellectual property rights to the new single crystal cathode technology on an exclusive and royalty-free basis.

    Novonix, through its wholly-owned subsidiary Novonix BTS, has filed a patent application to protect these new single crystal cathode methods. This is on top of the patent applications already filed to protect the DPMG process.

    What now?

    Commenting on today’s update, Novonix managing director Phil St Baker said:

    The Single Crystal Cathode development complements NOVONIX’s PUREgraphite anode product, both addressing the ultra-long-life battery performance requirements critical to the achieving the million-mile battery life being sought by leading EV automakers.

    Meanwhile, Professor Mark Obrovac, lead inventor of the DPMG and new single crystal cathode materials, shed some light on the research project by stating:

    A major focus of my lab’s research is the development of elegant dry processing methods for battery materials that are amenable to scaling, while simultaneously increasing yields, eliminating waste, and enabling the use of inexpensive feedstocks. Along the way we found out that these new methods can enable the synthesis of new advanced materials with properties that have not been previously accessible by more conventional methods. This has created a tremendous opportunity for the advancement of practical battery materials.

    More details regarding the developed methods and materials will be published by Professor Obrovac and his team in the coming months. 

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading over 30% off it’s all-time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    As of 2/6/2020

    More reading

    Motley Fool contributor Cathryn Goh has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Novonix share price skyrockets 77% after announcing patented manufacturing method appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30iFSQy

  • Beyond Meat Pops 22% On Sinodis Food Distribution Partnership In China

    Beyond Meat Pops 22% On Sinodis Food Distribution Partnership In ChinaShares in Beyond Meat (BYND) soared 22% after announcing a partnership with food distributor Sinodis to further expand the reach of its famous plant-based beef in China.The news sent shares up 22% to $162.46 on Monday. The financial terms of the partnership weren’t disclosed.Sinodis, a subsidiary of French group Savencia, is a distributor of imported food products to more than 4500 wholesalers, restaurant chains, and hotels in China."Our goal is to increase availability of plant-based meat globally, providing consumers with more choices, and access to nutritional and environmental benefits of plant-based meat," said Beyond Meat’s chief growth officer Chuck Muth. "China has a large population and a strong interest in plant-based proteins."The partnership strengthens Beyond Meat’s foothold in China. Back in April, the plant-based meat provider made the foray into the market in China announcing a partnership with Starbucks (SBUX). At the end of last month, the company teamed up with fast-food chains Kentucky Fried Chicken (KFC) and Pizza Hut.During May, Yum (YUM) China’s KFC also announced that it will begin its first Chinese trial of a plant-based version of its popular fried chicken. According to the company’s Weibo page, U.S. agribusiness Cargill Ltd will supply the nuggets.Beyond Meat’s expansion plans have helped the value of its share price triple since mid-March 18. Following the impressive rally, the $85.78 average analyst price target now indicates 47% downside potential from current levels. (See Beyond Meat stock analysis on TipRanks)However, one of the analysts still sees more gains in the offing for Beyond Meat’s stock. Five-star analyst Peter Saleh at BTIG on May 19 initiated the stock with a Buy rating and a $173 price target, suggesting that shares have room to advance an additional 6.5% over the coming year, citing strong sales growth in coming years.“The company’s stated goal is to tackle the $1.4 trillion global meat industry,” Saleh wrote in a note to investors, adding that about $270 billion of that is spent in the U.S. “The adoption of Beyond’s products by mainstream customers in the suburbs will be the key to long-term success. We expect the company to expand into other protein categories including poultry to help broaden its appeal.”The analyst forecasts sales to grow 56% in 2020 and 51% in 2021.The rest of Wall Street analysts remain sidelined on Beyond Meat’s stock right now. The Hold analyst consensus is divided into 5 Hold and 5 Sell ratings versus 3 Buy ratings.Related News: Beyond Meat Teams Up With KFC, Pizza Hut In China Hormel Stock Rises After It Reports Record Sales Papa John’s U.S. Pizza Sales Jump 33.5%; Shares Pop 7% In Pre-Market More recent articles from Smarter Analyst: * Gilead Seeks Europe Remdesivir Approval; Three Analysts Reiterate Bullish Calls * Global Blood Therapeutics Up On Expanded Use Plans For Sickle Cell Treatment * Chesapeake Energy Gearing Up For Bankruptcy Filing- Report * Google Maps To Roll Out Covid-19 Alerts On Travel Restrictions

    from Yahoo Finance https://ift.tt/2zffg7N

  • Results From Oxford University’s Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

  • Alcoa CEO Sees No Certainty a Definitive Recovery Is Coming

  • More consumers show interest in traveling on cruises in the near term: Analyst

  • Synovus Financial Corp. Earnings Missed Analyst Estimates: Here’s What Analysts Are Forecasting Now